Trials / Enrolling By Invitation
Enrolling By InvitationNCT06268951
Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.
Detailed description
The purpose of this study is to characterize the recovery and symptom relief following cryoablation of abdominal wall endometriosis. Patients undergoing clinically indicated ablation of abdominal wall endometriosis will receive an endometriosis-specific symptom survey (Endometriosis Health Profile - 30) prior to ablation and then at 3-, 6-, 12-, and 24-months following treatment. A 2 question survey related to pain at the treatment site will also be administered prior to ablation and then at 1-, 7-, and 30-days after ablation.
Conditions
Timeline
- Start date
- 2024-05-09
- Primary completion
- 2027-02-01
- Completion
- 2027-12-01
- First posted
- 2024-02-21
- Last updated
- 2025-05-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06268951. Inclusion in this directory is not an endorsement.